Endoscopic third ventriculostomy for the management of hydrocephalus secondary to posterior fossa tumors: A retrospective study.
Brain
Endoscopic third ventriculostomy
Posterior fossa
Resection
Tumors
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
09
2021
accepted:
05
01
2022
entrez:
4
3
2022
pubmed:
5
3
2022
medline:
5
3
2022
Statut:
epublish
Résumé
Endoscopic third ventriculostomy (ETV) is an effective alternative to ventriculoperitoneal shunting as well as external ventricular drainage for the urgent management of acute hydrocephalus. We performed this study to investigate the efficacy and safety of ETV before tumor resection in managing hydrocephalus in patients with posterior fossa brain tumors (PFBT) in our neurosurgery department. We conducted this retrospective observational study between February 2018 and February 2020 on all cases diagnosed with PFBT associated with triventricular obstructive hydrocephalus. We retrospectively reviewed the demographic characteristics, operative procedures, and radiological investigations of all cases. During the follow-up period, clinical, as well as radiological success were evaluated. Twenty-two ETV procedures were performed in 22 cases of PFBT (mean age = 22.1 years, SD = 11.4). Of the 22 cases, 8 cases (36.4%) had ependymoma, 7 cases (31.8%) had cerebellar astrocytoma, and 5 cases (22.7 %) had medulloblastoma, while 2 cases (9.1%) had diffuse pontine gliomas. The median follow-up duration was 9 months (range 3-13 months). The most commonly reported clinical presentation was the significant intracranial pressure increase. All operations were performed successfully in all cases. Only two ETV post-tumor resection failures were documented during the follow-up period. Preoperative ETV has shown to be an effective long-term cerebrospinal fluid diversion procedure to manage PFBT-associated hydrocephalus, with a relatively low rate of complications. Further prospective studies are required to assess the regular use of ETV before complete tumor resection.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic third ventriculostomy (ETV) is an effective alternative to ventriculoperitoneal shunting as well as external ventricular drainage for the urgent management of acute hydrocephalus. We performed this study to investigate the efficacy and safety of ETV before tumor resection in managing hydrocephalus in patients with posterior fossa brain tumors (PFBT) in our neurosurgery department.
METHODS
METHODS
We conducted this retrospective observational study between February 2018 and February 2020 on all cases diagnosed with PFBT associated with triventricular obstructive hydrocephalus. We retrospectively reviewed the demographic characteristics, operative procedures, and radiological investigations of all cases. During the follow-up period, clinical, as well as radiological success were evaluated.
RESULTS
RESULTS
Twenty-two ETV procedures were performed in 22 cases of PFBT (mean age = 22.1 years, SD = 11.4). Of the 22 cases, 8 cases (36.4%) had ependymoma, 7 cases (31.8%) had cerebellar astrocytoma, and 5 cases (22.7 %) had medulloblastoma, while 2 cases (9.1%) had diffuse pontine gliomas. The median follow-up duration was 9 months (range 3-13 months). The most commonly reported clinical presentation was the significant intracranial pressure increase. All operations were performed successfully in all cases. Only two ETV post-tumor resection failures were documented during the follow-up period.
CONCLUSION
CONCLUSIONS
Preoperative ETV has shown to be an effective long-term cerebrospinal fluid diversion procedure to manage PFBT-associated hydrocephalus, with a relatively low rate of complications. Further prospective studies are required to assess the regular use of ETV before complete tumor resection.
Identifiants
pubmed: 35242431
doi: 10.25259/SNI_971_2021
pii: 10.25259/SNI_971_2021
pmc: PMC8888306
doi:
Types de publication
Journal Article
Langues
eng
Pagination
65Informations de copyright
Copyright: © 2022 Surgical Neurology International.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Acta Neurochir Suppl. 2012;113:149-53
pubmed: 22116442
J Neurosurg. 2015 Dec;123(6):1456-62
pubmed: 26230473
J Neurosurg Pediatr. 2018 Oct 12;23(1):104-108
pubmed: 30497212
Childs Nerv Syst. 2019 May;35(5):789-794
pubmed: 30895380
J Neurosurg. 2001 Nov;95(5):791-7
pubmed: 11702869
Neurosurgery. 2010 Sep;67(3):588-93
pubmed: 20647973
J Neurol Surg A Cent Eur Neurosurg. 2018 Mar;79(2):123-129
pubmed: 29241270
Childs Nerv Syst. 2004 Nov;20(11-12):828-33
pubmed: 15221247
Acta Neurochir (Wien). 2018 May;160(5):1063-1071
pubmed: 29455408
Childs Nerv Syst. 2011 Jan;27(1):117-26
pubmed: 20737274
Dement Neuropsychol. 2019 Apr-Jun;13(2):133-143
pubmed: 31285787
Pediatr Neurosurg. 1994;20(4):240-7
pubmed: 8043462
Neurosurg Focus. 2005 Dec 15;19(6):E8
pubmed: 16398485
Pediatr Neurosurg. 2007;43(2):92-6
pubmed: 17337918
J Korean Neurosurg Soc. 2017 May;60(3):282-288
pubmed: 28490153
Surg Neurol. 1997 Mar;47(3):210-2
pubmed: 9068689
Neurosurgery. 1999 Apr;44(4):795-804; discussion 804-6
pubmed: 10201305
J Neurosurg Pediatr. 2014 Nov;14 Suppl 1:30-4
pubmed: 25988780
Neurocrit Care. 2018 Jun;28(3):338-343
pubmed: 29305758
Pediatr Neurosurg. 2009;45(3):186-91
pubmed: 19494562
Childs Nerv Syst. 2011 Oct;27(10):1723-34
pubmed: 21928036
Neurosurg Focus. 2020 Jan 1;48(1):E5
pubmed: 31896082
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Neurosurg Pediatr. 2013 Sep;12(3):220-6
pubmed: 23808727
Neurosurgery. 2016 Jan;78(1):109-19
pubmed: 26295500
Childs Nerv Syst. 2015 Oct;31(10):1781-9
pubmed: 26351230
Childs Nerv Syst. 2019 Aug;35(8):1283-1293
pubmed: 31129704
Neurol India. 2011 Nov-Dec;59(6):848-54
pubmed: 22234198
Childs Nerv Syst. 2010 Dec;26(12):1699-704
pubmed: 20502903